Phoundry Pharmaceuticals Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Phoundry Pharmaceuticals General Information

Description

Owner and operator of a peptide therapeutic company. The company offers services for identification of therapeutically valuable peptide hormone targets and the optimization of peptide ligands to drugs and also discovers peptide therapeutic drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare
Acquirer
Primary Office
  • 6 Davis Drive
  • Research Triangle Park
  • Durham, NC 27709
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoundry Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 24-Sep-2015 00000 Completed Startup
2. Seed Round 06-Aug-2015 00000 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Phoundry Pharmaceuticals’s complete valuation and funding history, request access »

Phoundry Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Paul Feldman Ph.D Co-Founder, Chief Executive Officer and Board Member
Mark Paulik Ph.D Co-Founder & Director, Biology
Shane Roller Ph.D Co-Founder & Director, DMPK
James Way Co-Founder & Director, Molecular Pharmacology
Andrew Young Ph.D Co-Founder, Chief Scientific Officer and Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Phoundry Pharmaceuticals Board Members (1)

Name Representing Role Since
Paul Feldman Ph.D Phoundry Pharmaceuticals Co-Founder, Chief Executive Officer and Board Member 000 0000
To view Phoundry Pharmaceuticals’s complete board members history, request access »

Phoundry Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biosciences Accelerator Accelerator/Incubator Minority 000 0000 000000 0
To view Phoundry Pharmaceuticals’s complete investors history, request access »